Molecular basis of traditional chinese medicine in cancer chemoprevention

Current Drug Discovery Technologies

Volumn 7, Issue 1, 2010, Pages 67-75

  Wang, Steven ^a   Penchala, Sravan ^a   Prabhu, Sunil ^a   Wang, Jeffrey ^a   Huang, Ying ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Chemoprevention; NF B; Nrf2 and COX 2; Traditional Chinese medicine

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SHI QUAN DA BU TANG; TRANSCRIPTION FACTOR NRF2;

ANGELICA SINENSIS; APOPTOSIS; CANCER MORTALITY; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL GROWTH; CELL INVASION; CHEMOPROPHYLAXIS; CHINESE MEDICINE; DOWN REGULATION; ENZYME INHIBITION; HERB; HUANG QIN; HUMAN; JIANG HUANG; METASTASIS; MORBIDITY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; QIANG HUO; REVIEW; SALVIA MILTIORRHIZA; STRESS; TEA; ZI CAO;

ANIMALS; ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 77951717597     PISSN: 15701638     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016310791162794     Document Type: Review

References (94)

1. Jeong WS, Jun M, Kong AN. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal 2006; 8(1-2): 99-106. (Pubitemid 43324535)
2. Mukhtar H, Ahmad N. Cancer chemoprevention: future holds in multiple agents. Toxicol Appl Pharmacol 1999; 158(3): 207-210 (Pubitemid 29382938)
3. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57(1): 43-66.
4. Walaszek Z, Hanausek M, Slaga TJ. Mechanisms of chemoprevention. Chest 2004; 125(5 Suppl): 128S-33S.
5. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2(1): 48-58. (Pubitemid 37328807)
6. Rao CV, Reddy BS. NSAIDs and chemoprevention. Curr Cancer Drug Targets 2004; 4(1): 29-42.
7. Hawk ET, Umar A, Viner JL. Colorectal cancer chemoprevention-an overview of the science. Gastroenterology 2004; 126(5): 1423-1447 (Pubitemid 38552806)
8. Cuzick J, Otto F, Baron JA, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: An international consensus statement. Lancet Oncol 2009; 10(5): 501-507.
9. Parekh HS, Liu G, Wei MQ. A new dawn for the use of traditional Chinese medicine in cancer therapy. Mol Cancer 2009; 8: 21.
10. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441(7092): 431-436 (Pubitemid 44050137)
11. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998; 281(5383): 1680-1683 (Pubitemid 28435585)
12. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-260 (Pubitemid 28183365)
13. Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat Immunol 2002; 3(1): 20-26 (Pubitemid 34065613)
14. Chabot-Fletcher M. A role for transcription factor NF-kappa B in inflammation. Inflamm Res 1997; 46(1): 1-2. (Pubitemid 27068293)
15. Khan N, Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 2008; 269(2): 269-280
16. Surh YJ, Chun KS, Cha HH, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 2001; 480-81: 243-268
17. D'Acquisto F, Iuvone T, Rombola L, et al. Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett 1997; 418(1-2): 175-178 (Pubitemid 27514441)
18. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269(7): 4705-4708 (Pubitemid 24239438)
19. Meunier J, Hayashi T. Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB. J Pharmacol Exp Ther 2010; 332(2): 388-397
20. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006; 354(3): 270-282
21. Miller EC, Miller JA. Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules. Pharmacol Rev 1966; 18(1): 805-838
22. Kwak MK, Wakabayashi N, Kensler TW. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers. Mutat Res 2004; 555(1-2): 133-148 (Pubitemid 39345402)
23. Sporn MB. The war on cancer. Lancet 1996; 347(9012): 1377-1381
24. Kensler TW. Chemoprevention by inducers of carcinogen detoxication enzymes. Environ Health Perspect 1997; 105(Suppl 4): 965-970
25. Fahey JW, Talalay P. Antioxidant functions of sulforaphane: a potent inducer of Phase II detoxication enzymes. Food Chem Toxicol 1999; 37(9-10): 973-979 (Pubitemid 29481800)
26. McMahon M, Itoh K, Yamamoto M, et al. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 2001; 61(8): 3299-3307 (Pubitemid 32695017)
27. Thimmulappa RK, Mai KH, Srisuma S, et al. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 2002; 62(18): 5196-5203 (Pubitemid 35033454)
28. Zhang Y, Gordon GB. A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway. Mol Cancer Ther 2004; 3(7): 885-893 (Pubitemid 39193771)
29. Gately S, Li WW. Multiple roles of COX-2 in tumor angiogenesis: A target for antiangiogenic therapy. Semin Oncol 2004; 31(2 Suppl 7): 2-11. (Pubitemid 38879409)
30. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev 2000; 19(1-2): 19-27.
31. Hung WC. Anti-metastatic action of non-steroidal anti-inflammatory drugs. Kaohsiung J Med Sci 2008; 24(8): 392-397
32. Wu KK. Biochemical pharmacology of nonsteroidal anti-inflammatory drugs. Biochem Pharmacol 1998; 55(5): 543-547 (Pubitemid 28077812)
33. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J 1998; 12(12): 1063-1073
34. Simmons DL, Botting RM, Hla T. Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004; 56(3): 387-437. (Pubitemid 39096597)
35. Jana NR. NSAIDs and apoptosis. Cell Mol Life Sci 2008; 65(9): 1295-1301
36. Kundu N, Smyth MJ, Samsel L, Fulton AM. Cyclooxygenase inhibitors block cell growth, increase ceramide and inhibit cell cycle. Breast Cancer Res Treat 2002; 76(1): 57-64. (Pubitemid 35178628)
37. Yang CS, Chin KV, Lambert JD. Cancer chemoprevention by targeting proteasomal degradation: Commentary re Dragnev KA et al, Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: Implications for combination therapy. Clin Cancer Res 2004; 10(7): 2220-2221
38. Kardosh A, Blumenthal M, Wang WJ, Chen TC, Schonthal AH. Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines. Cancer Biol Ther 2004; 3(1): 55-62. (Pubitemid 41342419)
39. Boyle JO, Langenfeld J, Lonardo F, et al. Cyclin D1 proteolysis: A retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. J Natl Cancer Inst 1999; 91(4): 373-379 (Pubitemid 29102338)
40. Freemantle SJ, Liu X, Feng Q, et al. Cyclin degradation for cancer therapy and chemoprevention. J Cell Biochem 2007; 102(4): 869-877 (Pubitemid 350036927)
41. Dragnev KH, Feng Q, Ma Y, et al. Uncovering novel targets for cancer chemoprevention. Recent Results Cancer Res 2007; 174: 235-243
42. Bush KT, Goldberg AL, Nigam SK. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem 1997; 272(14): 9086-9092
43. Kaufman RJ. Orchestrating the unfolded protein response in health and disease. J Clin Invest 2002; 110(10): 1389-1398 (Pubitemid 35396907)
44. Guo LQ, Taniguchi M, Chen QY, Baba K, Yamazoe Y. Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: Properties of umbelliferous or citrus crude drugs and their relative prescriptions. Jpn J Pharmacol 2001; 85(4): 399-408. (Pubitemid 32421731)
45. Yang XW, Gu ZM, Wang BX, Hattori M, Namba T. Comparison of anti-lipid peroxidative effects of the underground parts of Notopterygium incisum and N. forbesii in mice. Planta Med 1991; 57(5): 399-402.
46. Okuyama E, Nishimura S, Ohmori S, et al. Analgesic component of Notopterygium incisum Ting. Chem Pharm Bull (Tokyo) 1993; 41(5): 926-929 (Pubitemid 23240056)
47. Wang S, Wang T. Chemical constituents of Notopterygium forbesii Boiss. Zhongguo Zhong Yao Za Zhi 1996; 21(5): 295-96, 319.
48. Tang SY, Wang H, Zhang W, Halliwell B. Notopterygium forbesii boiss extract and its active constituents increase reactive species and heme oxygenase-1 in human fetal hepatocytes: Mechanisms of action. Chem Res Toxicol 2008; 21(12): 2414-2423
49. Tang SY, Cheah IK, Wang H, Halliwell B. Notopterygium forbesii Boiss extract and its active constituent phenethyl ferulate attenuate pro-inflammatory responses to lipopolysaccharide in RAW 264.7 macrophages. A "protective" role for oxidative stress? Chem Res Toxicol 2009; 22(8): 1473-1482
50. Zee-Cheng RK. Shi-quan-da-bu-tang (ten significant tonic decoction), SQT. A potent Chinese biological response modifier in cancer immunotherapy, potentiation and detoxification of anticancer drugs. Methods Find Exp Clin Pharmacol 1992; 14(9): 725-736
51. Hamada M, Fujii Y, Yamamoto H, et al. Effect of a kanpo medicine, zyuzentaihoto, on the immune reactivity of tumor-bearing mice. J Ethnopharmacol 1988; 24(2-3): 311-320 (Pubitemid 19022074)
52. Yang WJ, Li DP, Li JK, et al. Synergistic antioxidant activities of eight traditional Chinese herb pairs. Biol Pharm Bull 2009; 32(6): 1021-1026
53. Chu Q, Hashimoto K, Satoh K, Wang Q, Sakagami H. Effect of three herbal extracts on NO and PGE2 production by activated mouse macrophage-like cells. In vivo 2009; 23(4): 537-544
54. Lin Z, Zhu D, Yan Y, et al. An Antioxidant Phytotherapy to Rescue Neuronal Oxidative Stress. Evid Based Complement Alternat Med 2008; [Epub ahead of print].
55. Dietz BM, Liu D, Hagos GK, et al. Angelica sinensis and its alkylphthalides induce the detoxification enzyme NAD(P)H: quinone oxidoreductase 1 by alkylating Keap1. Chem Res Toxicol 2008; 21(10): 1939-1948.
56. Chiu PY, Leung HY, Siu AH, et al. Dang-Gui Buxue Tang protects against oxidant injury by enhancing cellular glutathione in H9c2 cells: role of glutathione synthesis and regeneration. Planta Med 2007; 73(2): 134-141
57. Cheng TO. Danshen: what every cardiologist should know about this Chinese herbal drug. Int J Cardiol 2006; 110(3): 411-412
58. Zhou L, Zuo Z, Chow MS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005; 45(12): 1345-1359 (Pubitemid 41643896)
59. Park EJ, Zhao YZ, Kim YC, Sohn DH. Preventive effects of a purified extract isolated from Salvia miltiorrhiza enriched with tanshinone I, tanshinone IIA and cryptotanshinone on hepatocyte in jury in vitro and in vivo. Food Chem Toxicol 2009; 47(11): 2742-2748
60. Fan GW, Gao XM, Wang H, et al. The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS. J Steroid Biochem Mol Biol 2009; 113(3-5): 275-280
61. Wu WL, Chang WL, Chen CF. Cytotoxic activities of tanshinones against human carcinoma cell lines. Am J Chin Med 1991; 19(3-4): 207-216
62. Mosaddik MA. In vitro cytotoxicity of tanshinones isolated from Salvia miltiorrhiza Bunge against P388 lymphocytic leukemia cells. Phytomedicine 2003; 10(8): 682-685
63. Tang Z, Tang Y, Fu L. Growth inhibition and apoptosis induction in human hepatoma cells by tanshinone II A. J Huazhong Univ Sci Technolog Med Sci 2003; 23(2): 166-68, 172. (Pubitemid 41559748)
64. Wang X, Wei Y, Yuan S, et al. Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer 2005; 116(5): 799-807. (Pubitemid 41099713)
65. Su CC, Chen GW, Kang JC, Chan MH. Growth inhibition and apoptosis induction by tanshinone IIA in human colon adenocarcinoma cells. Planta Med 2008; 74(11): 1357-1362
66. Yang R, Liu A, Ma X, et al. Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation. J Cardiovasc Pharmacol 2008; 51(4): 396-401. (Pubitemid 351572239)
67. Fu J, Huang H, Liu J, et al. Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol 2007; 568(1-3): 213-221 (Pubitemid 46976900)
68. Sun Z, Huang Z, Zhang DD. Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PLoS One 2009; 4(8): e6588.
69. Yuan X, Xu C, Pan Z, et al. Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells. Mol Carcinog 2006; 45(11): 841-850 (Pubitemid 44646336)
70. Zhang HS, Wang SQ. Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells. Biochem Pharmacol 2007; 73(9): 1358-1366
71. Chen TH, Hsu YT, Chen CH, Kao SH, Lee HM. Tanshinone IIA from Salvia miltiorrhiza induces heme oxygenase-1 expression and inhibits lipopolysaccharide-induced nitric oxide expression in RAW 264.7 cells. Mitochondrion 2007; 7(1-2): 101-105
72. Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 2004; 23(14): 2507-2522 (Pubitemid 38520748)
73. Afaq F, Adhami VM, Ahmad N, Mukhtar H. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate. Oncogene 2003; 22(7): 1035-1044 (Pubitemid 36313147)
74. Afaq F, Ahmad N, Mukhtar H. Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene 2003; 22(58): 9254-9264 (Pubitemid 38122037)
75. Surh YJ, Chun KS. Cancer chemopreventive effects of curcumin. Adv Exp Med Biol 2007; 595: 149-172
76. Pan MH, Lin-Shiau SY, Lin JK. Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol 2000; 60(11): 1665-1676
77. Yadav VS, Mishra KP, Singh DP, Mehrotra S, Singh VK. Immunomodulatory effects of curcumin. Immunopharmacol Immunotoxicol 2005; 27(3): 485-497
78. Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 1995; 49(11): 1551-1556
79. Jin B, Li YP. Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss. J Cell Biochem 2007; 100(4): 960-969 (Pubitemid 46273019)
80. Ireson C, Orr S, Jones DJ, et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 2001; 61(3): 1058-1064
81. Goel A, Boland CR, Chauhan DP. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 2001; 172(2): 111-118 (Pubitemid 32889704)
82. Lev-Ari S, Maimon Y, Strier L, Kazanov D, Arber N. Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines. J Soc Integr Oncol 2006; 4(1): 21-26 (Pubitemid 44249829)
83. Lee JS, Surh YJ. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 2005; 224(2): 171-184 (Pubitemid 40725839)
84. Chen X, Yang L, Oppenheim JJ, Howard MZ. Cellular pharmacology studies of shikonin derivatives. Phytother Res 2002; 16(3): 199-209. (Pubitemid 34534943)
85. Min R, Tong J, Wenjun Y, et al. Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by Shikonin was partly through the inactivation of NF-kappaB pathway. Phytother Res 2008; 22(3): 407-415 (Pubitemid 351397447)
86. Lee HJ, Magesh V, Nam D, et al. Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in lewis lung carcinoma-bearing mice. Yakugaku Zasshi 2008; 128(11): 1681-1688
87. Lim ES, Rhee YH, Park MK, et al. DMNQ S-64 induces apoptosis via caspase activation and cyclooxygenase-2 inhibition in human nonsmall lung cancer cells. Ann NY Acad Sci 2007; 1095: 7-18.
88. Park MJ, Kwon HY, Lee EO, et al. DMNQ-S17 inhibits constitutive NF-kappaB activation leading to induction of apoptosis through the activation of caspase-3 in human myeloid leukemia U937 cells. Life Sci 2008; 83(13-14): 460-467
89. Huang H, Xie BF, Zhu XF, et al. Antitumor effect and mechanism of shikonin derivative SYUNZ-7. Ai Zheng 2005; 24(12): 1453-1458
90. Nelson PS, Montgomery B. Unconventional therapy for prostate cancer: good, bad or questionable? Nat Rev Cancer 2003; 3(11): 845-858
91. Peng CY, Pan SL, Huang YW, et al. Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cellcycle progression and inhibiting ERK, Akt, and NF-kappaB activity in vascular smooth-muscle cells. Naunyn Schmiedebergs Arch Pharmacol 2008; 378(6): 579-588
92. Pidgeon GP, Kandouz M, Meram A, Honn KV. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells. Cancer Res 2002; 62(9): 2721-2727 (Pubitemid 34462758)
93. Chan FL, Choi HL, Chen ZY, Chan PS, Huang Y. Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin. Cancer Lett 2000; 160(2): 219-228
94. Kang BY, Chung SW, Kim SH, Cho D, Kim TS. Involvement of nuclear factor-kappaB in the inhibition of interleukin-12 production from mouse macrophages by baicalein, a flavonoid in Scutellaria baicalensis. Planta Med 2003; 69(8): 687-691 (Pubitemid 37215014)